Athenex, Inc. (ATNX): Price and Financial Metrics
Athenex, Inc. (ATNX)
Today's Latest Price: $13.70 USD
Updated Jan 28 9:04am
Add ATNX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 241 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ATNX Stock Summary
- Athenex Inc's stock had its IPO on June 14, 2017, making it an older stock than just 12.14% of US equities in our set.
- With a year-over-year growth in debt of 107.33%, Athenex Inc's debt growth rate surpasses 88.96% of about US stocks.
- Revenue growth over the past 12 months for Athenex Inc comes in at 78.06%, a number that bests 93.39% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Athenex Inc, a group of peers worth examining would be BBI, QUIK, TMDX, RIGL, and ACLS.
- Visit ATNX's SEC page to see the company's official filings. To visit the company's web site, go to www.athenex.com.
ATNX Stock Price Chart Interactive Chart >
ATNX Price/Volume Stats
| Current price | $13.70 | 52-week high | $15.67 |
| Prev. close | $13.85 | 52-week low | $5.63 |
| Day low | $13.70 | Volume | 7,111 |
| Day high | $13.70 | Avg. volume | 831,845 |
| 50-day MA | $12.32 | Dividend yield | N/A |
| 200-day MA | $11.82 | Market Cap | 1.28B |
Athenex, Inc. (ATNX) Company Bio
Athenex Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company was founded in 2003 and is based in Buffalo, New York.
Loading social stream, please wait...